早期乳腺癌保乳加放疗与全乳切除加重建的长期生活质量比较
该比较效果研究基于德州癌症登记处2006-2008年诊断的0-II期乳腺癌患者,2017-2018年邮寄调查,共647例回应(保乳356例,全切加重建291例),中位随访10.3年。多因素分析显示两组乳房满意度和躯体健康无显著差异,但全切加重建组心理社会健康和性健康显著更差,健康效用和决策后悔无差异。
要点
- 保乳加放疗与全切加重建在乳房满意度和躯体健康上无显著差异。
- 全切加重建组心理社会健康和性健康显著更差,具临床意义。
- 健康效用和局部治疗决策后悔两组无差异。
核心结论
- 保乳加放疗与全切加重建在乳房满意度和躯体健康方面等效。
- 保乳加放疗与心理社会和性健康方面具临床意义的改善相关。
研究设计与样本
- 比较效果研究,使用德州癌症登记处2006-2008年诊断的0-II期乳腺癌女性数据。
- 2017年3月至2018年4月邮寄调查,647例回应(回应率40.0%),其中551例确认治疗。
- 中位年龄53岁(范围23-85岁),中位诊断至调查时间10.3年(范围8.4-12.5年)。
临床怎么用
- 为早期乳腺癌女性提供偏好敏感性决策支持时,可告知两种方案在乳房满意度和躯体健康上等效。
- 需告知全切加重建可能伴随心理社会健康和性健康更差,保乳加放疗可能改善这些方面。
局限性
- 回应率40.0%,可能存在无应答偏倚。
- 仅85.2%回应者确认治疗,暴露分类存在一定不确定性。
- 为观察性比较效果研究,无法完全排除混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Treatment options for early breast cancer include breast-conserving surgery with radiation therapy (RT) or mastectomy and breast reconstruction without RT. Despite marked differences in these treatment strategies, little is known with regard to their association with long-term quality of life (QOL). OBJECTIVE: To evaluate the association of treatment with breast-conserving surgery with RT vs mastectomy and reconstruction without RT with long-term QOL. DESIGN, SETTING, AND PARTICIPANTS: This comparative effectiveness research study used data from the Texas Cancer Registry for women diagnosed with stage 0-II breast cancer and treated with breast-conserving surgery or mastectomy and reconstruction between 2006 and 2008. The study sample was mailed a survey between March 2017 and April 2018. Data were analyzed from August 1, 2018 to October 15, 2021. EXPOSURES: Breast-conserving surgery with RT or mastectomy and reconstruction without RT. MAIN OUTCOMES AND MEASURES: The primary outcome was satisfaction with breasts, measured with the BREAST-Q patient-reported outcome measure. Secondary outcomes included BREAST-Q physical well-being, psychosocial well-being, and sexual well-being; health utility, measured using the EuroQol Health-Related Quality of Life 5-Dimension, 3-Level questionnaire; and local therapy decisional regret. Multivariable linear regression models with weights for treatment, age, and race and ethnicity tested associations of the exposure with outcomes. RESULTS: Of 647 patients who responded to the survey (40.0%; 356 had undergone breast-conserving surgery, and 291 had undergone mastectomy and reconstruction), 551 (85.2%) confirmed treatment with breast-conserving surgery with RT (n = 315) or mastectomy and reconstruction without RT (n = 236). Among the 647 respondents, the median age was 53 years (range, 23-85 years) and the median time from diagnosis to survey was 10.3 years (range, 8.4-12.5 years). Multivariable analysis showed no significant difference between breast-conserving surgery with RT (referent) and mastectomy and reconstruction without RT in satisfaction with breasts (effect size, 2.71; 95% CI, -2.45 to 7.88; P = .30) or physical well-being (effect size, -1.80; 95% CI, -5.65 to 2.05; P = .36). In contrast, psychosocial well-being (effect size, -8.61; 95% CI, -13.26 to -3.95; P < .001) and sexual well-being (effect size, -10.68; 95% CI, -16.60 to -4.76; P < .001) were significantly worse with mastectomy and reconstruction without RT. Health utility (effect size, -0.003; 95% CI, -0.03 to 0.03; P = .83) and decisional regret (effect size, 1.32; 95% CI, -3.77 to 6.40; P = .61) did not differ by treatment group. CONCLUSIONS AND RELEVANCE: The findings support equivalence of breast-conserving surgery with RT and mastectomy and reconstruction without RT with regard to breast satisfaction and physical well-being. However, breast-conserving surgery with RT was associated with clinically meaningful improvements in psychosocial and sexual well-being. These findings may help inform preference-sensitive decision-making for women with early-stage breast cancer.
引用
- Hanson SE, Lei X, Roubaud MS, et al. Long-term Quality of Life in Patients With Breast Cancer After Breast Conservation vs Mastectomy and Reconstruction. JAMA Surg. 2022. PMID: 35416926. doi:10.1001/jamasurg.2022.0631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。